• 1
    Russell WO, Cohen J, Enzinger FM, Hajdu SI, Heise H, Martin RG, et al. A clinical and pathological staging system for soft tissue sarcomas. Cancer 1977; 40: 156270.
  • 2
    HajduSI, editor. History and classification of soft tissue tumors. In: Pathology of soft tissue tumors. Philadelphia: Lea & Febiger, 1979: 155.
  • 3
    Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980; 153: 10620.
  • 4
    Markhede G, Angervall L, Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer 1982; 49: 172133.
  • 5
    Rydholm A, Berg NO, Gullberg B, Persson BM, Thomgren K-G. Prognosis for soft-tissue sarcoma in the locomotor system: a retrospective population-based follow-up study of 237 patients. Acta Pathol Microbiol Immunol Scand [A] 1984; 92: 37586.
  • 6
    EnzingerFM, WeissSW, editors. Staging and grading of soft tissue sarcomas. In: Soft tissue tumors. St. Louis: CV Mosby, 1983: 813.
  • 7
    Myhre-Jensen O, Kaae S, Madsen EH, Sneppen O. Histopathological grading in soft-tissue tumours: relation to survival in 261 surgically treated patients. Acta Pathol Microbiol Immunol Scand [A] 1983; 91: 114550.
  • 8
    Myhre-Jensen O, Hogh J, Ostgaard SE, Nordentoft M, Sneppen O. Histopathological grading of soft tissue tumours: prognostic significance in a prospective study of 278 consecutive cases. J Pathol 1991; 163: 1924.
  • 9
    Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas: results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 1984; 53: 53041.
  • 10
    Lack EE, Steinberg SM, White DE, Kinsella T, Glatstein E, Chang AE, et al. Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas. J Surg Oncol 1989; 41: 26373.
  • 11
    Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, et al. Soft-tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33: 3742.
  • 12
    Tsujimoto M, Aozasa K, Ueda T, Morimura Y, Komatsubara Y, Doi T. Multivariate analysis for histologic prognostic factors in soft tissue sarcomas. Cancer 1988; 62: 9948.
  • 13
    Hashimoto H, Enjoji M. Liposarcoma: a clinicopathologic sub-typing of 52 cases. Acta Pathol Jpn 1982; 32: 93348.
  • 14
    GrossAJ, ClarkeVA, editors. Survival distributions: reliability applications in the biomedical sciences. New York John Wiley & Sons, 1975.
  • 15
    SAS Institute Inc. SAS user's guide: statistics, version 5. Cary, NC: The Institute, 1990: 50728.
  • 16
    Shiraki M, Enterline HT, Brooks JJ, Cooper NS, Hirschl S, Roth JA, et al. Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas, and mesotheliomas: the Eastern Cooperative Oncology Group (ECOG) experience. Cancer 1989; 64: 48490.
  • 17
    Kreicbergs A, Tribukait B, Willems J, Bauer HCF. DNA flow analysis of soft tissue tumors. Cancer 1987; 59: 12833.
  • 18
    Alvegård TA, Berg NO, Baldetorp B, Femo M, Killander D, Ranstam J, et al. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience. J Clin Oncol 1989; 8: 53847.
  • 19
    Kroese MCS, Rutgers DH, Wils IS, van Unnik JAM, Roholl PJM. The relevance of the DNA index and proliferation rate in the grading of benign and malignant soft tissue tumors. Cancer 1990; 65: 17828.
  • 20
    Swanson SA, Brooks JJ. Proliferation markers Ki-67 and p105 in soft-tissue lesions: correlation with DNA flow cytometric characteristics. Am J Pathol 1990; 137: 1491500.
  • 21
    Aganval V, Greenebaum E, Wersto R, Koss LG. DNA ploidy of spindle cell soft-tissue tumors and its relationship to histology and clinical outcome. Arch Pathol Lab Med 1991; 115: 55862.
  • 22
    Ueda T, Aozasa K, Tsujimoto M, Ohsawa M, Uchida A, Aoki Y, et al. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer 1989; 63: 160711.
  • 23
    Zehr RJ, Bauer TW, Marks KE, Weltevreden A. Ki-67 and grading of malignant fibrous histiocytomas. Cancer 1990; 66: 198490.
  • 24
    Robbins BA, de la Vega D, Ogata K, Tan EM, Nakamura RM. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med 1987; 111: 8415.
  • 25
    Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissue: comparison with flow cytometric analysis. Am J Pathol 1989; 134: 7339.
  • 26
    Yu CC-W, Hall PA, Fletcher CDM, Camplejohn RS, Waseem NH, Lane DP, et al. Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA). Histopathology 1991; 19: 2933.